{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T06:41:04Z","timestamp":1787985664195,"version":"build-2784847793"},"reference-count":50,"publisher":"Impact Journals, LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2014,5,3]]},"DOI":"10.18632\/aging.100655","type":"journal-article","created":{"date-parts":[[2016,3,6]],"date-time":"2016-03-06T04:41:43Z","timestamp":1457239303000},"page":"311-319","source":"Crossref","is-referenced-by-count":20,"title":["Cardiac BNP gene delivery prolongs survival in aged spontaneously hypertensive rats with overt hypertensive heart disease"],"prefix":"10.18632","volume":"6","author":[{"given":"Jason M.","family":"Tonne","sequence":"first","affiliation":[{"name":"Department of Molecular Medicine, Mayo Clinic, College of Medicine, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara J.","family":"Holditch","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Mayo Clinic, College of Medicine, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise A","family":"Oehler","sequence":"additional","affiliation":[{"name":"Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Departments of Medicine and Physiology, Mayo Clinic, College of Medicine, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire A.","family":"Schreiber","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Mayo Clinic, College of Medicine, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Mayo Clinic, College of Medicine, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Cataliotti","sequence":"additional","affiliation":[{"name":"Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Departments of Medicine and Physiology, Mayo Clinic, College of Medicine, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2014,5,3]]},"reference":[{"key":"1","first-page":"1","article-title":"The Heart as an Endocrine Organ","volume":"3","author":"Chidsey","year":"1964","journal-title":"The American journal of medicine"},{"key":"2","first-page":"78","article-title":"A new natriuretic peptide in porcine brain","volume":"33","author":"Matsuo","year":"1988","journal-title":"Nature"},{"key":"3","first-page":"89","article-title":"A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats","volume":"2","author":"Sonnenberg","year":"1981","journal-title":"Life Sci"},{"key":"4","first-page":"6057","article-title":"Guanylyl cyclase-linked natriuretic peptide receptors: structure and regulation","volume":"27","author":"Hunter","year":"2001","journal-title":"The Journal of biological chemistry"},{"key":"5","first-page":"943","article-title":"BNP-induced activation of cGMP in human cardiac fibroblasts: interactions with fibronectin and natriuretic peptide receptors","volume":"20","author":"Noser","year":"2006","journal-title":"Journal of cellular physiology"},{"key":"6","first-page":"17442","article-title":"Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure","volume":"10","author":"Muddiman","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"7","first-page":"933","article-title":"Effect of plasma protein depletion on BNP-32 recovery","volume":"5","author":"Burnett","year":"2008","journal-title":"Clinical chemistry"},{"key":"8","first-page":"348","article-title":"Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure","volume":"4","author":"Vasan","year":"2009","journal-title":"Nature genetics"},{"key":"9","first-page":"H1529","article-title":"Lack of activation of molecular forms of the BNP system in human grade 1 hypertension and relationship to cardiac hypertrophy","volume":"29","author":"Bonaiuto","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10","first-page":"E21","article-title":"Deficiency of the cardiorenal protective hormone BNP in early stages of hypertension","volume":"2","author":"McKie","year":"2010","journal-title":"Journal of Hypertension"},{"key":"11","first-page":"1558","article-title":"Human Hypertension Is Characterized by a Lack of Activation of the Antihypertensive Cardiac Hormones ANP and BNP","volume":"6","author":"Costello-Boerrigter","year":"2012","journal-title":"Journal of the American College of Cardiology"},{"key":"12","first-page":"1297","article-title":"Long-term cardiac pro-B-type natriuretic peptide gene delivery prevents the development of hypertensive heart disease in spontaneously hypertensive rats","volume":"12","author":"Bellavia","year":"2011","journal-title":"Circulation"},{"key":"13","first-page":"45","article-title":"Natriuretic Peptide Signaling via Guanylyl Cyclase (GC)-A: An Endogenous Protective Mechanism of the Heart","volume":"5","author":"Kangawa","journal-title":"Curr Cardiol Rev"},{"key":"14","first-page":"1127","article-title":"Brain natriuretic Peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases","volume":"9","author":"Huntley","year":"2002","journal-title":"Circulation research"},{"key":"15","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/CIRCHEARTFAILURE.110.958033","article-title":"Intramyocardial BNP gene delivery improves cardiac function through distinct context-dependent mechanisms","volume":"4","author":"Mustonen","year":"2011","journal-title":"Circ Heart Fail"},{"key":"16","first-page":"4239","article-title":"Cardiac fibrosis in mice lacking brain natriuretic peptide","volume":"9","author":"Chusho","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"17","first-page":"1291","article-title":"Impact of high-normal blood pressure on the risk of cardiovascular disease","volume":"34","author":"Leip","year":"2001","journal-title":"The New England journal of medicine"},{"key":"18","first-page":"621","article-title":"(2013) Genetics of longevity in model organisms: debates and paradigm shifts","volume":"7","author":"Partridge","year":"2013","journal-title":"Annu Rev Physiol"},{"key":"19","doi-asserted-by":"crossref","first-page":"861","DOI":"10.18632\/aging.100525","article-title":"Answering the ultimate question \u201cwhat is the proximal cause of aging?\u201d","volume":"4","author":"Blagosklonny","year":"2012","journal-title":"Aging"},{"key":"20","first-page":"321","article-title":"Alternative Perspectives on Aging in Caenorhabditis elegans: Reactive Oxygen Species or Hyperfunction?","volume":"1","author":"de la Guardia","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"21","first-page":"1321","article-title":"Mammalian target of rapamycin is a critical regulator of cardiac hypertrophy in spontaneously hypertensive rats","volume":"5","author":"Hu","year":"2009","journal-title":"Hypertension"},{"key":"22","first-page":"851","article-title":"Late-life rapamycin treatment reverses age-related heart dysfunction","volume":"1","author":"Zambataro","year":"2013","journal-title":"Aging Cell"},{"key":"23","article-title":"Weekly administration of rapamycin improves survival and biomarkers in obese male mice on high-fat diet","author":"Blagosklonny","year":"2014","journal-title":"Aging Cell"},{"key":"24","first-page":"729","article-title":"Inhibition of Mammalian Target of Rapamycin With Rapamycin Reverses Hypertrophic Cardiomyopathy in Mice With Cardiomyocyte-Specific Knockout of PTEN","volume":"6","author":"Ren","year":"2014","journal-title":"Hypertension"},{"key":"25","first-page":"148","article-title":"Identification of mutated Srebf1 as a QTL influencing risk for hepatic steatosis in the spontaneously hypertensive rat","volume":"5","author":"Landa","year":"2008","journal-title":"Hypertension"},{"key":"26","first-page":"3242","article-title":"Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies","volume":"9","author":"Magnusson","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"27","first-page":"1400","article-title":"B-type natriuretic peptide (BNP) affects the initial response to intravenous glucose: a randomised placebo-controlled cross-over study in healthy men","volume":"5","author":"Resl","year":"2012","journal-title":"Diabetologia"},{"key":"28","first-page":"1345","article-title":"Natriuretic peptides: a new lipolytic pathway in human adipocytes","volume":"1","author":"Galitzky","year":"2000","journal-title":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology"},{"key":"29","article-title":"B-type natriuretic peptide inhibits angiotensin II-induced proliferation and migration of pulmonary arterial smooth muscle cells","author":"Yang","year":"2013","journal-title":"Pediatr Pulmonol"},{"key":"30","first-page":"170","article-title":"B-type natriuretic peptide protects cardiomyocytes at reperfusion via mitochondrial calcium uniporter","volume":"6","author":"Zheng","year":"2010","journal-title":"Biomed Pharmacother"},{"key":"31","first-page":"165","article-title":"NPRA-mediated suppression of AngII-induced ROS production contribute to the antiproliferative effects of B-type natriuretic peptide in VSMC","volume":"32","author":"Huang","year":"2009","journal-title":"Mol Cell Biochem"},{"key":"32","first-page":"26","article-title":"Brain Natriuretic Peptide (BNP) regulates the production of inflammatory mediators in human THP-1 macrophages","volume":"14","author":"Baldini","year":"2008","journal-title":"Regul Pept"},{"key":"33","first-page":"1022","article-title":"Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes","volume":"12","author":"Amri","year":"2012","journal-title":"The Journal of clinical investigation"},{"key":"34","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMoa0706300","article-title":"Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation","volume":"35","author":"Zingman","year":"2008","journal-title":"The New England journal of medicine"},{"key":"35","first-page":"86","article-title":"Brain natriuretic peptide is a marker associated with thrombus in stroke patients with atrial fibrillation","volume":"30","author":"Kimura","year":"2011","journal-title":"J Neurol Sci"},{"key":"36","first-page":"530","article-title":"Elevated B-type natriuretic peptide level as a marker of subsequent thromboembolic events in patients with atrial fibrillation","volume":"2","author":"Ogawa","year":"2011","journal-title":"Heart Vessels"},{"key":"37","first-page":"I9","article-title":"Risk factors for venous thromboembolism","volume":"10","author":"Spencer","year":"2003","journal-title":"Circulation"},{"key":"38","first-page":"13206","article-title":"Multiple roles for sialylated glycans in determining the cardiopulmonary tropism of adeno-associated virus 4","volume":"8","author":"Asokan","year":"2013","journal-title":"Journal of virology"},{"key":"39","first-page":"316","article-title":"Adeno-associated virus serotypes: vector toolkit for human gene therapy","volume":"1","author":"Samulski","year":"2006","journal-title":"Molecular therapy : the journal of the American Society of Gene Therapy"},{"key":"40","first-page":"229","article-title":"Adeno-associated virus vectorology, manufacturing, and clinical applications","volume":"50","author":"Samulski","year":"2012","journal-title":"Methods Enzymol"},{"key":"41","first-page":"194ra192","article-title":"Overcoming preexisting humoral immunity to AAV using capsid decoys","volume":"5","author":"Pavani","year":"2013","journal-title":"Sci Transl Med"},{"key":"42","first-page":"2357","article-title":"Adenovirus-associated virus vector-mediated gene transfer in hemophilia B","volume":"36","author":"Rangarajan","year":"2011","journal-title":"The New England journal of medicine"},{"key":"43","first-page":"2160","article-title":"The human visual cortex responds to gene therapy-mediated recovery of retinal function","volume":"12","author":"Monroe","journal-title":"The Journal of clinical investigation"},{"key":"44","first-page":"443","article-title":"Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector","volume":"2","author":"Li","year":"2012","journal-title":"Molecular therapy : the journal of the American Society of Gene Therapy"},{"key":"45","first-page":"304","article-title":"Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure","volume":"12","author":"Mancini","year":"2011","journal-title":"Circulation"},{"key":"46","first-page":"171","article-title":"Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1\/2 clinical trial","volume":"1","author":"Mancini","year":"2009","journal-title":"Journal of cardiac failure"},{"key":"47","first-page":"e3","article-title":"Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo","volume":"9","author":"Thattaliyath","year":"2006","journal-title":"Circulation research"},{"key":"48","first-page":"1605","article-title":"Systemic AAV-9 transduction in mice is influenced by animal age but not by the route of administration","volume":"1","author":"Duan","year":"2007","journal-title":"Gene therapy"},{"key":"49","first-page":"413","article-title":"Sustained blood pressure-lowering actions of subcutaneous B-type natriuretic peptide (nesiritide) in a patient with uncontrolled hypertension","volume":"8","author":"Burnett","year":"2012","journal-title":"Mayo Clinic proceedings"},{"key":"50","first-page":"1635","article-title":"Incidence and prognosis of resistant hypertension in hypertensive patients","volume":"12","author":"Magid","year":"2012","journal-title":"Circulation"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.100655","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T15:28:00Z","timestamp":1599060480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.100655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,3]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4,1]]}},"alternative-id":["100655","24799459"],"URL":"https:\/\/doi.org\/10.18632\/aging.100655","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,3]]}}}